Anteis Overview

  • Founded
  • 2003
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Anteis General Information


Developer and distributor of injectable medical devices. The company manufactures medical devices based on biopolymer transformation. It offers anti-age treatments, viscoelastic gels, which are manufactured from animals and pain reliever treatments for osteoarthritis problems.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Monitoring Equipment
Merz Pharma
Primary Office
  • Rue de Veyrot 11
  • 1217 Meyrin
  • Switzerland
+41 022 000 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anteis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 08-Nov-2013 00.000 Completed Generating Revenue
2. Later Stage VC 30-Mar-2009 00.000 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 30-Nov-2007 Completed Product Development
To view Anteis’s complete valuation and funding history, request access »

Anteis Executive Team (3)

Name Title Board Seat Contact Info
Gilles Bos Chief Executive Officer
Sylvain Ducret Chief Financial Officer
Marco Ruedi MD Managing Director
To view Anteis’s complete executive team members history, request access »

Anteis Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BB Biotech Ventures Venture Capital Minority 000 0000 000000 0
Fongit Seed Invest Venture Capital Minority 000 0000 000000 0
Matignon Investissement et Gestion Venture Capital Minority 000 0000 000000 0
Signet Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
To view Anteis’s complete investors history, request access »